Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,1013,120 of 20,252 grants

Active NON-SBIR/STTR RPGS
Development of Magnetic Resonance Fingerprinting (MRF) to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

Abstract In women, breast cancer is the most commonly diagnosed cancer and leading cause of cancer related deaths worldwide, with approximately 2.3 million new cases and 685,000 de...

$5.64M
USD
Active NON-SBIR/STTR RPGS
Local Tumoral Delivered Immune Checkpoint Blockades Immunotherapy and Radioembolization Combination Therapy
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2023 – 2028

PROJECT SUMMARY Systemic mono- or combination- immune checkpoint blockade (ICB) immunotherapy has been an established therapeutic paradigm. However, a risk of serious autoimmune si...

$3.57M
USD
Active NON-SBIR/STTR RPGS
Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR)
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2028

PROJECT SUMMARY / ABSTRACT Cancer is the second most frequent cause of death in children under 15-years of age, and primary central nervous system (CNS) tumors are the most frequen...

$2.66M
USD
Active NON-SBIR/STTR RPGS
NCI-sponsored Clinical Trial Research Specialist
NATIONAL CANCER INSTITUTE University of Florida United States 2023 – 2028

ABSTRACT NCI-sponsored clinical trials represent some of the highest priority clinical trials conducted by the UF Health Cancer Center (UFHCC). These trials include participation b...

$1.15M
USD
Active NON-SBIR/STTR RPGS
Blockade of cMYC oncogenic function by pregnancy-induced alterations and remodeling of the mammary gland
NATIONAL CANCER INSTITUTE Cold Spring Harbor Laboratory United States 2023 – 2028

Abstract/Project Summary The goal of this proposal is to understand how transitions through pregnancy influence the molecular and cellular state of mammary epithelial cells and onc...

$5.1M
USD
Completed NON-SBIR/STTR RPGS
Investigating facilitator-driven, multi-level implementation strategies in Federally Qualified Health Centers to improve provider recommendation and HPV vaccination rates among Latino/a adolescents
NATIONAL CANCER INSTITUTE University of Texas At Austin United States 2023 – 2024

Project Summary/Abstract Approximately 46,143 new cases of human papillomavirus (HPV) associated cancers occur annually in the U.S and there are substantial racial, ethnic, socioec...

$3.51M
USD
Active OTHER RESEARCH-RELATED
Differential Wnt Dependencies in Colon Epithelium.
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2028

Project Summary/Abstract This proposal details a five-year training plan for the development of a research program focused on elucidating the therapeutic potential of superimposed...

$1.96M
USD
Completed OTHER RESEARCH-RELATED
Investigating CD4+ T cell memory in cancer immunotherapy
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2024

Project Summary/Abstract This proposal encompasses a 5-year research and training plan to support the transition of Dr. Wattenberg to an independent research career. Dr. Wattenberg...

$1.79M
USD
Active NON-SBIR/STTR RPGS
Inferring Kinase Activity from Tumor Phosphoproteomic Data
NATIONAL CANCER INSTITUTE University of Virginia United States 2023 – 2026

Project Summary Kinases are fundamentally important enzymes for regulating cell physiology through regulation of proteins and protein interactions by phosphorylating tyrosine, seri...

$4.05M
USD
Completed OTHER RESEARCH-RELATED
Transcriptome and spatial analyses of tumor environment in addressing colorectal cancer racial and ethnical disparities
NATIONAL CANCER INSTITUTE University of Washington United States 2023 – 2025

PROJECT ABSTRACT Colorectal cancer (CRC) is the third leading cause of cancer-related death in the US, with pronounced disparities in mortality by race and ethnicity. Disparities a...

$491.9K
USD
Completed OTHER RESEARCH-RELATED
Dissecting the tumor cell-immune TME axis to identify therapeutically actionable vulnerabilities that potentiate immunotherapy in GBM
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2025

Glioblastoma multiforme (GBM) is a common and highly aggressive form of brain cancer in adults with a dismal prognosis and limited therapeutic options. A critical component of GBM...

$491.9K
USD
Completed OTHER RESEARCH-RELATED
Identifying Inflammatory Mediators of Clonal Hematopoiesis
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT Clonal hematopoiesis (CH) is a common phenomenon defined as the presence of somatic mutations in hematopoietic stem and progenitor cells (HSPCs) and their...

$491.9K
USD
Completed OTHER RESEARCH-RELATED
Defining the role of chromosomal break end synapsis factors for DNA repair
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2024

SUMMARY. Clastogenic cancer therapeutics, i.e., agents that induce chromosomal DNA double-strand breaks (DSBs), such as radiotherapy, remain a cornerstone of cancer treatment. A ce...

$331.9K
USD
Completed OTHER RESEARCH-RELATED
Fertility experiences among ethnically diverse adolescent and young adult cancer survivors: A population-based study
NATIONAL CANCER INSTITUTE University of Southern California United States 2023 – 2024

PROJECT SUMMARY/ABSTRACT Curative cancer treatment modalities (e.g., chemotherapy) are gonadotoxic (i.e., destroy sperm and eggs) and frequently cause infertility. Thus, clinical p...

$491.9K
USD
Completed OTHER RESEARCH-RELATED
Understanding metabolic and vascular vulnerabilities of residual disease in triple negative breast cancer to inform on treatment strategies
NATIONAL CANCER INSTITUTE Duke University United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT Recurrence of cancer cells that evade therapy is a leading cause of death. Given that residual disease can persist for years to decades following therapy,...

$405K
USD
Completed OTHER RESEARCH-RELATED
Impact of neurofibromin on ER-alpha and nuclear speck post-transcriptional gene regulation
NATIONAL CANCER INSTITUTE Van Andel Research Institute United States 2023 – 2025

PROJECT SUMMARY Alternative splicing (AS) of transcripts is an essential post-transcriptional process that is instrumental for numerous cell functions including proliferation, diff...

$481.9K
USD
Completed OTHER RESEARCH-RELATED
Elucidating the role of mRNA m6A methylation in tumorigenesis
NATIONAL CANCER INSTITUTE University of Chicago United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT The current lack of effective, targeted cancer therapies reflects a gap in knowledge surrounding the mechanisms that promote tumorigenesis and emphasizes t...

$491.9K
USD
Completed OTHER RESEARCH-RELATED
Real Time Metabolic Imaging to Interrogate Early Detection and Prevention of Pancreatic Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2025

Project Summary Pancreatic ductal adenocarcinoma (PDAC) has a median 5-year survival of only 11%, and early diagnosis of PDAC is recognized as one of the highest priority areas by...

$371.8K
USD
Completed OTHER RESEARCH-RELATED
Discerning mechanisms of semaphorin 7A-mediated tumor progression via immunoevasion
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2023 – 2025

Project We Summary/Abstract have identified that semaphorin 7a (SEMA7A)—a signaling molecule that activates integrin-β1 signaling in cancer—is upregulated in postpartum breast canc...

$366.7K
USD
Active NON-SBIR/STTR RPGS
Multi-omics for obesity-associated liver disease discovery in Hispanics/Latinos: the Cameron County Hispanic Cohort
NATIONAL CANCER INSTITUTE University of Texas Hlth Sci Ctr Houston United States 2023 – 2028

ABSTRACT We submit “Multi-omics for obesity-associated liver disease discovery in Hispanics/Latinos: the Cameron County Hispanic Cohort” (hereafter CCHC-Liver) in response to RFA-H...

$8M
USD